Uric acid as a biomarker and a therapeutic target in diabetes.

Uric acid as a biomarker and a therapeutic target in diabetes.

Item
http://www.wikidata.org/entity/Q38323538
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study.Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis.New and old agents in the management of diabetic nephropathy.Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond.The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.Evaluation of various equations for estimating renal function in elderly Chinese patients with type 2 diabetes mellitus.Effects of Shizhifang on NLRP3 Inflammasome Activation and Renal Tubular Injury in Hyperuricemic Rats.Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and its kidney clearance: post-hoc analyses of four clinical trials.Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.Plasma uric acid effects on glomerular haemodynamic profile of patients with uncomplicated Type 1 diabetes mellitus.Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology.Association between urinary sodium excretion and uric acid, and its interaction on the risk of prehypertension among Chinese young adults.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study.Salivary Biomarkers of Oxidative Stress in Children with Chronic Kidney Disease
P2860

Uric acid as a biomarker and a therapeutic target in diabetes.

Item
http://www.wikidata.org/entity/Q38323538
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Uric acid as a biomarker and a therapeutic target in diabetes.
@en
type
label
Uric acid as a biomarker and a therapeutic target in diabetes.
@en
prefLabel
Uric acid as a biomarker and a therapeutic target in diabetes.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Uric acid as a biomarker and a therapeutic target in diabetes.
@en
P2093
P304
P31
P356
10.1016/J.JCJD.2014.10.013
P433
P478
P577
P5875
P698
P921